La sélection des médicaments traditionnels par le goût (seconde partie); Travail du laboratoire de Pharmacie Chimique et Chimie Thérapeutique = Traditional drugs selection with flavour (second part) = Work of the laboratory of chemical pharmacy and therapeutical chemistryBulletin de la Société de pharmacie de Lille. 1994, Vol 50, Num 4, pp 58-88, issn 0366-3507Thesis

Psychiatrie : Acquisitions thérapeutiques 1998 (II) = PsychiatryBRYOIS, C; BERTSCHY, G; FERRERO, F et al.Médecine et hygiène. 1999, Vol 57, Num 2238, pp 113-115, issn 0025-6749, 2 p.Article

Cardiac conduction disturbances after an overdose of nefazodone and gabapentinRASIMAS, Joseph J; BURKHART, Keith K.The American journal of emergency medicine. 2006, Vol 24, Num 7, pp 886-888, issn 0735-6757, 3 p.Article

Antidepressant and statin interactions : A review and case report of simvastatin and nefazodone-induced rhabdomyolysis and transaminitisKARNIK, Niranjan S; MALDONADO, José R.Psychosomatics (Washington, DC). 2005, Vol 46, Num 6, pp 565-568, issn 0033-3182, 4 p.Article

Nefazodone in out-patient treatment of inhaled cocaine dependence: a randomized double-blind placebo-controlled trialLAMBERT PASSOS, Sonia Regina; BASTOS CAMACHO, Luiz Antonio; LOPES, Claudia S et al.Addiction (Abingdon. Print). 2005, Vol 100, Num 4, pp 489-494, issn 0965-2140, 6 p.Article

WomenYONKERS, K. A; BRAWMAN-MINTZER, O.Handbook of experimental pharmacology. 2003, Vol 157, pp 379-392, issn 0171-2004, 14 p.Article

Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depressionGELENBERG, Alan J; TRIVEDI, Madhukar H; KEITNER, Gabor I et al.Biological psychiatry (1969). 2003, Vol 54, Num 8, pp 806-817, issn 0006-3223, 12 p.Article

An open pilot study of nefazodone in depression with anger attacks : Relationship between clinical response and receptor bindingMISCHOULON, David; DOUGHERTY, Darin D; BOTTONARI, Kathryn A et al.Psychiatry research. Neuroimaging. 2002, Vol 116, Num 3, pp 151-161, issn 0925-4927, 11 p.Article

Nefazodone treatment of dysthymic disorder: An open, long-term, prospective pilot studyDURSUN, Serdar M; BIRD, Diane; RONSON, Karen E et al.Progress in neuro-psychopharmacology & biological psychiatry. 2002, Vol 26, Num 4, pp 671-676, issn 0278-5846Article

Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depressionHICKS, J. A; ARGYROPOULOS, S. V; RICH, A. S et al.British journal of psychiatry (Print). 2002, Vol 180, Num JUN, pp 528-535, issn 0007-1250Article

Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combinationZAJECKA, John; DUNNER, David L; BORIAN, Frances E et al.The Journal of clinical psychiatry. 2002, Vol 63, Num 8, pp 709-716, issn 0160-6689Article

Which depressed patients respond to nefazodone and when?TRIVEDI, Madhukar H; RUSH, A. John; PAN, Ji-Yang et al.The Journal of clinical psychiatry. 2001, Vol 62, Num 3, pp 158-163, issn 0160-6689Article

Nefazodone in the adjunctive therapy of schizophrenia: An open-label exploratory studyROSENBERG, Paul B; ROSSE, Richard B; SCHWARTZ, Barbara L et al.Clinical neuropharmacology. 2000, Vol 23, Num 4, pp 222-225, issn 0362-5664Article

Nefazodone pharmacokinetics in Depressed children and adolescentsFINDLING, R. L; PRESKORN, S. H; MARCUS, R. N et al.Journal of the American Academy of Child and Adolescent Psychiatry. 2000, Vol 39, Num 8, pp 1008-1016, issn 0890-8567Article

SNaRIs, NaSSAs, and NaRIs : new agents for the treatment of depressionKENT, J. M.Lancet (British edition). 2000, Vol 355, Num 9207, pp 911-918, issn 0140-6736Article

Nefazodone overdose : A case reportCATALANO, G; CATALANO, M. C; TUMARKIN, N. B. B et al.Clinical neuropharmacology. 1999, Vol 22, Num 1, pp 63-65, issn 0362-5664Article

Nefazodone for patients with chronic fatigue syndromeHICKIE, I.Australian and New Zealand journal of psychiatry. 1999, Vol 33, Num 2, pp 278-280, issn 0004-8674Article

Nefazodone in post-traumatic stress disorder : results from six open-label trialsHIDALGO, R; HERTZBERG, M. A; MELLMAN, T et al.International clinical psychopharmacology. 1999, Vol 14, Num 2, pp 61-68, issn 0268-1315Article

Drug-drug interactions in pediatric psychopharmacologyTEN EICK, A. P; NAKAMURA, H; REE, M. D et al.The Pediatric clinics of North America. 1998, Vol 45, Num 5, pp x-xi, issn 0031-3955, 34 p.Article

Brain-to-blood partition and in vivo inhibition of 5-hydroxytryptamine reuptake and quipazine-mediated behaviour of nefazodone and its main active metabolites in rodentsNACCA, A; GUISO, G; FRACASSO, C et al.British journal of pharmacology. 1998, Vol 125, Num 7, pp 1617-1623, issn 0007-1188Article

Human CYP2D6 and metabolism of m-chlorophenylpiperazineROTZINGER, S; JIAN FANG; COUTTS, R. T et al.Biological psychiatry (1969). 1998, Vol 44, Num 11, pp 1185-1191, issn 0006-3223Article

Nefazodone in major depression : Adjunctive benzodiazepine therapy and tolerabilityRICKELS, K; SCHWEIZER, E; CASE, W. G et al.Journal of clinical psychopharmacology. 1998, Vol 18, Num 2, pp 145-153, issn 0271-0749Article

Rational drug use in the treatment of depressionCOHEN, L. J.Pharmacotherapy. 1997, Vol 17, Num 1, pp 45-61, issn 0277-0008Article

A preliminary open trial of nefazodone added to mood stabilizers for bipolar depressionGOLDBERG, Joseph F.Journal of affective disorders. 2013, Vol 144, Num 1-2, pp 176-178, issn 0165-0327, 3 p.Article

Comparison of the Bioactivation Potential of the Antidepressant and Hepatotoxin Nefazodone with Aripiprazole, a Structural Analog and Marketed DrugBAUMAN, Jonathan N; FREDERICK, Kosea S; SAWANT, Aarti et al.Drug metabolism and disposition. 2008, Vol 36, Num 6, pp 1016-1029, issn 0090-9556, 14 p.Article